Acumen Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable
Acumen Pharmaceuticals, Inc. (ABOS) reported Increase (Decrease) in Accounts Payable of $12.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $11.78M, a 1024.93% increase year-over-year.
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.05M.
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$128.00K, a 103.87% decline year-over-year.
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$1.42M.
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$5.09M, a 219.33% decline from fiscal 2024.
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2024 was $4.27M.
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$261.00K, a 147.28% decline from fiscal 2022.
- Acumen Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2022 was $552.00K, a 0.90% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $12.82M 10-Q · filed 2026-08-12 | $12.70M derived: sum of 3 quarters · filed 2026-08-12 | $11.28M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.05M 10-Q · filed 2026-05-12 | $919.00K derived: sum of 2 quarters · filed 2026-05-12 | -$502.00K derived: sum of 3 quarters · filed 2026-05-12 | $545.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$1.55M derived: sum of 2 quarters · filed 2026-03-26 | -$502.00K derived: sum of 3 quarters · filed 2026-08-12 | -$5.09M 10-K · filed 2026-03-26 |
| 2025-09-30 | -$1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$374.00K derived: sum of 2 quarters · filed 2026-08-12 | -$4.97M 10-Q · filed 2025-11-12 | -$1.66M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.54M 10-Q · filed 2026-08-12 | -$239.00K derived: sum of 3 quarters · filed 2026-08-12 | -$2.10M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$4.59M 10-Q · filed 2026-05-12 | -$1.29M derived: sum of 2 quarters · filed 2026-05-12 | -$3.15M derived: sum of 3 quarters · filed 2026-05-12 | -$2.02M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.45M derived: sum of 2 quarters · filed 2026-03-26 | $2.57M derived: sum of 3 quarters · filed 2026-03-26 | $4.27M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$737.00K derived: sum of 2 quarters · filed 2025-11-12 | $963.00K 10-Q · filed 2025-11-12 | $980.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.82M 10-Q · filed 2025-08-12 | $2.84M derived: sum of 3 quarters · filed 2025-08-12 | $2.18M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.70M 10-Q · filed 2025-05-13 | $1.72M derived: sum of 2 quarters · filed 2025-05-13 | $1.05M derived: sum of 3 quarters · filed 2025-05-13 | $2.32M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$645.00K derived: sum of 2 quarters · filed 2025-03-27 | $617.00K derived: sum of 3 quarters · filed 2025-03-27 | -$261.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$662.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $600.00K derived: sum of 2 quarters · filed 2024-11-12 | -$278.00K 10-Q · filed 2024-11-12 | -$722.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $384.00K 10-Q · filed 2024-08-13 | -$60.00K derived: sum of 3 quarters · filed 2024-08-13 | $356.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$878.00K 10-Q · filed 2024-05-14 | -$1.32M derived: sum of 2 quarters · filed 2024-05-14 | -$906.00K derived: sum of 3 quarters · filed 2024-05-14 | -$447.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$444.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$28.00K derived: sum of 2 quarters · filed 2024-03-26 | $431.00K derived: sum of 3 quarters · filed 2024-03-26 | $552.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $875.00K derived: sum of 2 quarters · filed 2023-11-13 | $996.00K 10-Q · filed 2023-11-13 | $1.70M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $459.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $580.00K 10-Q · filed 2023-08-08 | $1.29M derived: sum of 3 quarters · filed 2023-08-08 | $396.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $121.00K 10-Q · filed 2023-05-09 | $827.00K derived: sum of 2 quarters · filed 2023-05-09 | -$63.00K derived: sum of 3 quarters · filed 2023-05-09 | $291.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$184.00K derived: sum of 2 quarters · filed 2023-03-27 | $170.00K derived: sum of 3 quarters · filed 2023-03-27 | $557.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | -$890.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$536.00K derived: sum of 2 quarters · filed 2022-11-14 | -$149.00K 10-Q · filed 2022-11-14 | -$1.07M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $741.00K 10-Q · filed 2022-08-15 | -$182.00K derived: sum of 3 quarters · filed 2022-08-15 | $669.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $387.00K 10-Q · filed 2022-05-16 | -$536.00K derived: sum of 2 quarters · filed 2022-05-16 | $315.00K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$72.00K derived: sum of 2 quarters · filed 2022-03-28 | $308.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $851.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.23M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $380.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |